Stock Scorecard



Stock Summary for Quest Diagnostics Inc (DGX) - $255.63 as of 11/9/2026 12:45:50 PM EST

Total Score

11 out of 30

Safety Score

50 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for DGX

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for DGX

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for DGX

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for DGX

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for DGX (50 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 9
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for DGX

Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference 11/9/2026 5:40:00 PM
Quest Diagnostics' chief financial officer will speak live from London on Nov. 17 11/9/2026 5:38:00 PM
Form 144 QUEST DIAGNOSTICS INC Filed by: Plewman Patrick 11/9/2026 3:14:00 PM
Officer Patrick Plewman plans to sell 11,717 Quest Diagnostics (DGX) shares. 11/9/2026 3:13:00 PM
Quest Diagnostics pays $13M to settle allegations tied to Giants ticket perks 11/8/2026 6:19:00 PM
Form 144 QUEST DIAGNOSTICS INC For: 8 November By Investing.com 11/8/2026 5:19:00 PM
Form 144 QUEST DIAGNOSTICS INC For: 8 November By Investing.com 11/8/2026 4:49:00 PM
Form 144 QUEST DIAGNOSTICS INC For: 8 November By Investing.com 11/8/2026 4:46:00 PM
Quest Diagnostics pays $13M to settle allegations tied to Giants ticket perks 11/8/2026 11:56:00 AM
Quest Diagnostics, Name on Giants' Practice Complex, Settles Federal Kickback Claims for $13M 11/7/2026 6:34:00 PM

Financial Details for DGX

Company Overview

Ticker DGX
Company Name Quest Diagnostics Inc
Country N/A
Description Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.
Sector Name HEALTHCARE
Industry Name DIAGNOSTICS & RESEARCH
Most Recent Quarter 9/30/2026
Next Earnings Date N/A

Stock Price History

Last Day Price 255.63
Price 4 Years Ago 144.84
Last Day Price Updated 11/9/2026 12:45:50 PM EST
Last Day Volume 945,173
Average Daily Volume 1,048,153
52-Week High 256.99
52-Week Low 168.34
Last Price to 52 Week Low 51.85%

Valuation Measures

Trailing PE N/A
Industry PE 87.30
Sector PE 64.15
5-Year Average PE 18.03
Free Cash Flow Ratio 35.41
Industry Free Cash Flow Ratio 135.86
Sector Free Cash Flow Ratio 39.55
Current Ratio Most Recent Quarter 1.70
Total Cash Per Share 7.22
Book Value Per Share Most Recent Quarter 69.38
Price to Book Ratio 3.64
Industry Price to Book Ratio 308.98
Sector Price to Book Ratio 39.92
Price to Sales Ratio Twelve Trailing Months 2.34
Industry Price to Sales Ratio Twelve Trailing Months 6.59
Sector Price to Sales Ratio Twelve Trailing Months 22.17
Analyst Buy Ratings 7
Analyst Strong Buy Ratings 2

Share Statistics

Total Shares Outstanding 110,373,000
Market Capitalization 28,214,649,990
Institutional Ownership N/A

Dividends

Ex-Dividend Date 10/6/2026
Previous Dividend Amount 0.8600
Current Dividend Amount 0.8600
Total Years Dividend Increasing Dividend Contender - Increasing for 14 Years
Trailing Annual Dividend Rate 3.38
Trailing Annual Dividend Yield 1.33%
Forward Annual Dividend Rate 3.44
Forward Annual Dividend Yield 1.35%
5-Year Dividend Payments Count 20
3-Year Average Dividend Yield 1.94%
5-Year Average Dividend Yield 1.95%
1-Year Dividend Growth Rate Percentage 7.30%
3-Year Dividend Growth Rate Percentage 6.86%
5-Year Dividend Growth Rate Percentage 6.78%
All-Time Dividend Growth Rate Percentage 10.51%
Dividend Payout Ratio 33.67%

Income Statement

Quarterly Earnings Growth YOY 28.70%
Annual Earnings Growth 13.89%
Reported EPS 12 Trailing Months 10.04
Reported EPS Past Year 8.62
Reported EPS Prior Year 9.85
Net Income Twelve Trailing Months 1,129,000,000
Net Income Past Year 992,000,000
Net Income Prior Year 871,000,000
Quarterly Revenue Growth YOY 10.00%
5-Year Revenue Growth 3.18%
Operating Margin Twelve Trailing Months 15.60%

Balance Sheet

Total Cash Most Recent Quarter 797,000,000
Total Cash Past Year 420,000,000
Total Cash Prior Year 549,000,000
Net Cash Position Most Recent Quarter -4,743,000,000
Net Cash Position Past Year -4,747,000,000
Long Term Debt Past Year 5,167,000,000
Long Term Debt Prior Year 5,615,000,000
Total Debt Most Recent Quarter 5,540,000,000
Equity to Debt Ratio Past Year 0.58
Equity to Debt Ratio Most Recent Quarter 0.58
Total Stockholder Equity Past Year 7,170,000,000
Total Stockholder Equity Prior Year 6,778,000,000
Total Stockholder Equity Most Recent Quarter 7,632,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 1,375,000,000
Free Cash Flow Per Share Twelve Trailing Months 12.46
Free Cash Flow Past Year 1,359,000,000
Free Cash Flow Prior Year 909,000,000

Options

Put/Call Ratio 20.50
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 206.44
20-Day Bollinger Middle Band 232.43
20-Day Bollinger Upper Band 258.43
Beta 0.55
RSI 63.25
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 158.97

System

Modified 11/6/2026 8:29:43 PM EST